NO832738L - Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater - Google Patents

Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater

Info

Publication number
NO832738L
NO832738L NO832738A NO832738A NO832738L NO 832738 L NO832738 L NO 832738L NO 832738 A NO832738 A NO 832738A NO 832738 A NO832738 A NO 832738A NO 832738 L NO832738 L NO 832738L
Authority
NO
Norway
Prior art keywords
dichlorated
16alfa
precaution
derivatives
methyl
Prior art date
Application number
NO832738A
Other languages
English (en)
Other versions
NO157864B (no
NO157864C (no
Inventor
Jean Georges Teutsch
Roger Deraedt
Josette Benzoni
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO832738L publication Critical patent/NO832738L/no
Publication of NO157864B publication Critical patent/NO157864B/no
Publication of NO157864C publication Critical patent/NO157864C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/13—Monohydroxylic alcohols containing saturated rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO832738A 1982-10-05 1983-07-27 Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater. NO157864C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8216668A FR2533928A1 (fr) 1982-10-05 1982-10-05 Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
NO832738L true NO832738L (no) 1984-04-06
NO157864B NO157864B (no) 1988-02-22
NO157864C NO157864C (no) 1988-06-01

Family

ID=9277977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832738A NO157864C (no) 1982-10-05 1983-07-27 Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.

Country Status (22)

Country Link
US (1) US4515787A (no)
JP (1) JPS59116300A (no)
AT (1) AT385996B (no)
AU (1) AU563739B2 (no)
BE (1) BE897906A (no)
CA (1) CA1203234A (no)
CH (1) CH659251A5 (no)
DE (1) DE3336292A1 (no)
DK (1) DK164062C (no)
ES (1) ES8405812A1 (no)
FI (1) FI77668C (no)
FR (1) FR2533928A1 (no)
GB (1) GB2127827B (no)
HU (1) HU190506B (no)
IE (1) IE56022B1 (no)
IT (1) IT1197713B (no)
MA (1) MA19909A1 (no)
NL (1) NL8303409A (no)
NO (1) NO157864C (no)
OA (1) OA07558A (no)
SE (1) SE447388B (no)
ZA (1) ZA836538B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
GB8512738D0 (en) * 1984-09-04 1985-06-26 Gen Electric Silylation method
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
US7247607B2 (en) * 2001-11-08 2007-07-24 Green & Clean, Inc. Active soluble cleaning composite of natural state using soybean fatty acids and the making method thereof
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Also Published As

Publication number Publication date
IT8348990A1 (it) 1985-03-19
DE3336292A1 (de) 1984-04-05
IT1197713B (it) 1988-12-06
GB2127827B (en) 1986-01-29
CA1203234A (fr) 1986-04-15
FI833602A0 (fi) 1983-10-04
FI77668C (fi) 1989-04-10
DK164062C (da) 1992-09-28
DE3336292C2 (no) 1992-09-10
ES526212A0 (es) 1984-06-16
ES8405812A1 (es) 1984-06-16
NO157864B (no) 1988-02-22
NO157864C (no) 1988-06-01
MA19909A1 (fr) 1984-04-01
AU563739B2 (en) 1987-07-23
GB8326527D0 (en) 1983-11-02
NL8303409A (nl) 1984-05-01
JPH0412279B2 (no) 1992-03-04
FI833602L (fi) 1984-04-06
ZA836538B (en) 1984-10-31
HU190506B (en) 1986-09-29
CH659251A5 (fr) 1987-01-15
SE447388B (sv) 1986-11-10
US4515787A (en) 1985-05-07
BE897906A (fr) 1984-04-04
IE832337L (en) 1984-04-05
SE8304062L (sv) 1984-04-06
JPS59116300A (ja) 1984-07-05
AT385996B (de) 1988-06-10
DK456483A (da) 1984-04-06
IE56022B1 (en) 1991-03-27
SE8304062D0 (sv) 1983-07-20
ATA352783A (de) 1987-11-15
DK164062B (da) 1992-05-04
DK456483D0 (da) 1983-10-04
OA07558A (fr) 1985-03-31
FR2533928A1 (fr) 1984-04-06
FI77668B (fi) 1988-12-30
FR2533928B1 (no) 1985-05-03
GB2127827A (en) 1984-04-18
AU1982483A (en) 1984-04-12

Similar Documents

Publication Publication Date Title
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO803868L (no) Fremgangsmaate ved fremstilling av nye kinazolinderivater
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO820967L (no) Fremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.
NO803935L (no) Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO844978L (no) Fremgangsmaate ved fremstilling av nye aminoguanidinderivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO803247L (no) R fremgangsmaate ved fremstilling av nye pyridothienotriazine
NO841691L (no) Fremgangsmaate ved fremstilling av nye 5-acyl-2-(1h)-pyridinoner
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO802402L (no) R fremgangsmaate ved fremstilling av nye halovincamonderivate
NO157864C (no) Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.
NO831012L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamid
NO803044L (no) Fremgangsmaate ved fremstilling av nye derivater av 1,2,4-oxadiazolin-5-on
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater